x min read

Hot Biotech Stocks: ALT CERE CYTO GBIO

Hot Biotech Stocks: ALT CERE CYTO GBIO
Written by
Alex Carlson
Published on
December 7, 2023
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Insider Financial recaps our recent winners in the biotech sector and covers the new stocks added to our watchlist.Sign up below to get our market-moving reports on top small caps!This video covers ALT, CERE, LWLG, BYND, UPST, CVNA, PATH, AFRM, CHWY, GME, AI, CYTO, TRKA, GBIO.

VIDEO SUMMARY

ALT proves what a biotech can do with good data.ABBV buying CERE. Was on our watchlist from the price action, but someone knew. Stock has gone from $26 to $45 buyout in a matter of days.CYTO webcast on December 11. Just a 8.78m float.GBIO insider buying.

BOTTOM LINE

As we keep saying, there are always opportunities in the markets, and it’s our job to find winning stocks to trade. Huge gains can be made in such a short amount of time.It’s essential to look for stocks that have yet to run. There are plenty of opportunities, and we look at hundreds of stocks weekly for our subscribers.Remember, all it takes is one or two to become a winner, and you’ve crushed the market indices (and Jim Cramer) for the year.Good luck to all (except the shorts and Cramer)!

WHEN INSIDER FINANCIAL HAS A NEW COMPANY TO RESEARCH, IT IS IMPORTANT TO PAY ATTENTION. AFTER ALL, OUR FREE NEWSLETTER PROFILED MANY TRIPLE-DIGIT WINNERS FOR SUBSCRIBERS. WE ALWAYS ARE LOOKING FOR MOMENTUM BEFORE IT HAPPENS!

Disclosure: We have not been compensated for this article/video. Insider Financial is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You